|
What's New in Fermentation and Biotechnology January/February Issue
The year 2002 which has just departed beyond the horizon was nothing if not eventful -
some would say apocalyptic - for the fermentation, biotechnology,
and food ingredient industries. Acquisitions, mergers - both mega and minor -
and spin-offs, have left the bystander, if not the players themselves, reeling.
In pharmaceuticals none of the old-style companies who were involved in pharmaceuticals
as well as chemicals and food ingredients, have survived intact. This has all gone.
Virtually every pharmaceutical company, large or small, has shed its chemical activities
resulting in new speciality chemical companies such as Rhodia, [from Aventis],
ICI [from Astra-Zeneca], Roche Vitamins [from Roche] and Novartis Nutrition
[from Novartis], Syngenta [from Aventis and Schering]. .
But the survival of these mega pharma groups is conditional on the quality of their
research pipelines yielding novel products which may inherit the void left by products
whose patents have already or will soon expire. The new speciality chemical companies are
becoming involved in pharmaceutical intermediates, food ingredients and more recently
ingredients for the nutraceutical sector.
The common interest of both pharmaceuticals and speciality chemicals companies are
fermentation and biotechnology processes. Novel pharma products likely to be
commercialised by 2010 involve at least one biotechnology stage
[see our latest survey 'The Fermentation and Biotechnology Industries - Current Capacity
and Capacity Requirements']. There is keen interest in fermentation processes for food
ingredients [see our latest survey 'Industrial Enzymes for Starch, Dairy Detergents,
Textiles, Baking and Foods - Current Status and Outlook']. Many pharmaceutical
intermediates are based on chiral technology [see our latest survey 'Chiral Compounds for
Biotechnology - Production Costs, Economics and Technology'
The nutraceutical sector is interesting due to the broad range of products based
on fermentation processesas can be seen in various new surveys
We will be glad to send you details including Tables of Contents for any of the above surveys.
Happy New Year
|
Newsletter Archive
|